首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
PHASE-1 TRIAL OF MITOXANTRONE BY 24-HOUR CONTINUOUS INFUSION
被引:0
|
作者
:
ANDERSON, KC
论文数:
0
引用数:
0
h-index:
0
ANDERSON, KC
GARNICK, MB
论文数:
0
引用数:
0
h-index:
0
GARNICK, MB
MESHAD, MW
论文数:
0
引用数:
0
h-index:
0
MESHAD, MW
COHEN, GI
论文数:
0
引用数:
0
h-index:
0
COHEN, GI
PEGG, WJ
论文数:
0
引用数:
0
h-index:
0
PEGG, WJ
FREI, E
论文数:
0
引用数:
0
h-index:
0
FREI, E
ISRAEL, M
论文数:
0
引用数:
0
h-index:
0
ISRAEL, M
MODEST, E
论文数:
0
引用数:
0
h-index:
0
MODEST, E
CANELLOS, GP
论文数:
0
引用数:
0
h-index:
0
CANELLOS, GP
机构
:
来源
:
CANCER TREATMENT REPORTS
|
1983年
/ 67卷
/ 05期
关键词
:
D O I
:
暂无
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:435 / 438
页数:4
相关论文
共 50 条
[1]
PHASE-1 AND PHARMACOLOGICAL STUDIES OF PENTAMETHYLMELAMINE ADMINISTERED BY 24-HOUR INTRAVENOUS-INFUSION
CASPER, ES
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
CASPER, ES
GRALLA, RJ
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
GRALLA, RJ
LYNCH, GR
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
LYNCH, GR
JONES, BR
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
JONES, BR
WOODCOCK, TM
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
WOODCOCK, TM
GORDON, C
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
GORDON, C
KELSEN, DP
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
KELSEN, DP
YOUNG, CW
论文数:
0
引用数:
0
h-index:
0
机构:
CORNELL UNIV,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021
YOUNG, CW
CANCER RESEARCH,
1981,
41
(04)
: 1402
-
1406
[2]
A PHASE-1 TRIAL OF 14-DAY CONTINUOUS INTRAVENOUS-INFUSION MITOXANTRONE
KREISLE, WH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA CANC CTR, ROOM 4951, 1515 N CAMPBELL AVE, TUCSON, AZ 85724 USA
KREISLE, WH
ALBERTS, DS
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA CANC CTR, ROOM 4951, 1515 N CAMPBELL AVE, TUCSON, AZ 85724 USA
ALBERTS, DS
LIST, AF
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA CANC CTR, ROOM 4951, 1515 N CAMPBELL AVE, TUCSON, AZ 85724 USA
LIST, AF
MCCLOSKEY, T
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA CANC CTR, ROOM 4951, 1515 N CAMPBELL AVE, TUCSON, AZ 85724 USA
MCCLOSKEY, T
PLEZIA, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA CANC CTR, ROOM 4951, 1515 N CAMPBELL AVE, TUCSON, AZ 85724 USA
PLEZIA, P
PENG, YM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA CANC CTR, ROOM 4951, 1515 N CAMPBELL AVE, TUCSON, AZ 85724 USA
PENG, YM
GEORGE, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA CANC CTR, ROOM 4951, 1515 N CAMPBELL AVE, TUCSON, AZ 85724 USA
GEORGE, M
ANTI-CANCER DRUGS,
1991,
2
(03)
: 251
-
259
[3]
PHASE-I CLINICAL-TRIAL OF FAZARABINE AS A 24-HOUR CONTINUOUS INFUSION
BAILEY, H
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53792
BAILEY, H
TUTSCH, KD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53792
TUTSCH, KD
ARZOOMANIAN, RZ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53792
ARZOOMANIAN, RZ
TOMBES, MB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53792
TOMBES, MB
ALBERTI, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53792
ALBERTI, D
BRUGGINK, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53792
BRUGGINK, J
WILDING, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN CANC,MADISON,WI 53792
WILDING, G
CANCER RESEARCH,
1991,
51
(04)
: 1105
-
1108
[4]
PHASE-1 STUDY OF 5-AZACYTIDINE (NSC-102816) USING 24-HOUR CONTINUOUS INFUSION FOR 5 DAYS
LOMEN, PL
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT ONCOL,DETROIT,MI
LOMEN, PL
BAKER, LH
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT ONCOL,DETROIT,MI
BAKER, LH
NEIL, GL
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT ONCOL,DETROIT,MI
NEIL, GL
SAMSON, MK
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT ONCOL,DETROIT,MI
SAMSON, MK
CANCER CHEMOTHERAPY REPORTS PART 1,
1975,
59
(06):
: 1123
-
1126
[5]
PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF TOPOTECAN ADMINISTERED AS A 24-HOUR CONTINUOUS INFUSION
BLANEY, SM
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
BLANEY, SM
BALIS, FM
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
BALIS, FM
COLE, DE
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
COLE, DE
CRAIG, C
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
CRAIG, C
REID, JM
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
REID, JM
AMES, MM
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
AMES, MM
KRAILO, M
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
KRAILO, M
REAMAN, G
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
REAMAN, G
HAMMOND, D
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
HAMMOND, D
POPLACK, DG
论文数:
0
引用数:
0
h-index:
0
机构:
WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
POPLACK, DG
CANCER RESEARCH,
1993,
53
(05)
: 1032
-
1036
[6]
PHASE-I AND PHARMACOLOGICAL STUDY OF ACIVICIN BY 24-HOUR CONTINUOUS INFUSION
WEISS, GR
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV MED, BOSTON, MA 02115 USA
WEISS, GR
MCGOVREN, JP
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV MED, BOSTON, MA 02115 USA
MCGOVREN, JP
SCHADE, D
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV MED, BOSTON, MA 02115 USA
SCHADE, D
KUFE, DW
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV MED, BOSTON, MA 02115 USA
KUFE, DW
CANCER RESEARCH,
1982,
42
(09)
: 3892
-
3895
[7]
A 24-hour continuous infusion study of bivalirudin in the rat
Gleason, TG
论文数:
0
引用数:
0
h-index:
0
机构:
WIL Res Labs Inc, Ashland, OH 44805 USA
Gleason, TG
Chengelis, CP
论文数:
0
引用数:
0
h-index:
0
机构:
WIL Res Labs Inc, Ashland, OH 44805 USA
Chengelis, CP
Jackson, CB
论文数:
0
引用数:
0
h-index:
0
机构:
WIL Res Labs Inc, Ashland, OH 44805 USA
Jackson, CB
Lindstrom, P
论文数:
0
引用数:
0
h-index:
0
机构:
WIL Res Labs Inc, Ashland, OH 44805 USA
Lindstrom, P
INTERNATIONAL JOURNAL OF TOXICOLOGY,
2003,
22
(03)
: 195
-
206
[8]
PHASE-I TRIAL OF 5-FLUOROURACIL BY 24-HOUR INFUSION WEEKLY
HAAS, NB
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
HAAS, NB
HINES, JB
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
HINES, JB
HUDES, GR
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
HUDES, GR
JOHNSTON, N
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
JOHNSTON, N
OZOLS, RF
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
OZOLS, RF
ODWYER, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106
ODWYER, PJ
INVESTIGATIONAL NEW DRUGS,
1993,
11
(2-3)
: 181
-
185
[9]
PHASE-I PHARMACOKINETIC STUDY OF TOPOTECAN BY 24-HOUR CONTINUOUS-INFUSION WEEKLY
HAAS, NB
论文数:
0
引用数:
0
h-index:
0
机构:
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
HAAS, NB
LACRETA, FP
论文数:
0
引用数:
0
h-index:
0
机构:
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
LACRETA, FP
WALCZAK, J
论文数:
0
引用数:
0
h-index:
0
机构:
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
WALCZAK, J
HUDES, GR
论文数:
0
引用数:
0
h-index:
0
机构:
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
HUDES, GR
BRENNAN, JM
论文数:
0
引用数:
0
h-index:
0
机构:
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
BRENNAN, JM
OZOLS, RF
论文数:
0
引用数:
0
h-index:
0
机构:
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
OZOLS, RF
ODWYER, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
ODWYER, PJ
CANCER RESEARCH,
1994,
54
(05)
: 1220
-
1226
[10]
PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION
FLEMING, GF
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
FLEMING, GF
RATAIN, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
RATAIN, MJ
OBRIEN, SM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
OBRIEN, SM
SCHILSKY, RL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
SCHILSKY, RL
HOFFMAN, PC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
HOFFMAN, PC
RICHARDS, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
RICHARDS, JM
VOGELZANG, NJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
VOGELZANG, NJ
KASUNIC, DA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
KASUNIC, DA
EARHART, RH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637
EARHART, RH
JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1994,
86
(05)
: 368
-
372
←
1
2
3
4
5
→